Vaccination
(asked on 20th January 2015) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government which recommendations made by the Joint Committee on Vaccination and Immunisation (JCVI) have been implemented by the Secretary of State for Health since May 2010; and in each case, on what date the recommendation was made and on what date it was implemented.
The information requested is shown in the following table.
Recommendation from the Joint Committee on Vaccination and Immunisation | Date of recommendation | Date of implementation |
The use of rotavirus vaccine in the routine infant immunisation programme, if vaccine prices were much less than those at which they are currently being offered, so that such an immunisation programme is cost-effective. | February 2009 | July 2013 |
The use of herpes zoster (shingles) vaccine vaccination programme for adults aged 70 years up to and including 79 years provided that a vaccine is available at a cost effective price. | March 2010 (full statement) | September 20131 |
The use of the Respiratory Syncytial Virus (RSV) prophylactic medicine Palivizumab to prevent serious RSV disease in at risk pre-term infants. | October 2010 | October 20102 |
The annual influenza vaccination programme be extended to include children aged 2 to under 17 years of age. | July 2012 | September 20133 |
Notes
- This programme is being phased in with 71-79 year-olds being offered shingles vaccines on a “catch-up” basis alongside the routine cohort of 70 year-olds. In 2013, vaccine was offered to 70 and 79 year-olds.
- This programme is to protect at-risk pre-term infants for whom RSV infection is likely to cause serious illness or death. It is not managed centrally but commissioned through specialised commissioning. Guidance was provided to the National Health Service in “Immunisation against Infectious Disease” following this recommendation in 2010.
- The extension programme for children will be phased in over a number of years. This extension began in 2013-14 with all two and three year-olds being offered vaccination through general practitioner surgeries, and 5-11 year old children in seven areas being offered vaccination through pilot programmes.